---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-008282"
form_type: "8-K"
ticker: "AIM"
cik: "0000946644"
company_name: "AIM ImmunoTech Inc."
filed_at: "2025-02-26T23:59:59+00:00"
generated_at: "2026-05-26T04:15:04.850397+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# AIM ImmunoTech appoints David Chemerow as independent director; reduces stockholder meeting quorum to 33 1/3%

## Summary
- David Chemerow appointed as independent director, effective February 24, 2025.
- Chemerow brings 40+ years of finance, accounting, and operations leadership experience; former CFO of Comscore.
- Bylaws amended to reduce quorum for stockholder meetings from 40% to 33 1/3%.
- Chemerow will be compensated same as other directors; serves until 2025 Annual Meeting.

## SEC filing metadata
- accession: 0001493152-25-008282
- form_type: 8-K
- ticker: AIM
- cik: 0000946644
- company_name: AIM ImmunoTech Inc.
- filed_at: 2025-02-26T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946644/000149315225008282/0001493152-25-008282-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946644/000149315225008282/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-008282
- JSON: https://secwatch.observer/filing/0001493152-25-008282.json
- Plain text: https://secwatch.observer/filing/0001493152-25-008282.txt

## Key facts
- Executive change
  David I. Chemerow was appointed as Director at AIM ImmunoTech Inc..
  - Action: appointed
  - Role: Director
  source text: On February 26, 2025, AIM ImmunoTech Inc. (the "Company") issued a press release announcing the appointment of David I. Chemerow to its Board of Directors (the "Board"), effective February 24, 2025
  evidence_url: https://www.sec.gov/Archives/edgar/data/946644/000149315225008282/0001493152-25-008282-index.htm
- Governance Changes
  AIM ImmunoTech Inc.: Reduced quorum for stockholder meetings from 40% to 33 1/3% (effective 2025-02-24).
  - Change: bylaw amendment
  - Effective: 2025-02-24
  source text: On February 24, 2025, the Company adopted Restated and Amended Bylaws. The Restated and Amended Bylaws revise Section 1.6 Quorum, reducing the quorum for stockholder meetings from 40% to 33 and 1/3%.
  evidence_url: https://www.sec.gov/Archives/edgar/data/946644/000149315225008282/0001493152-25-008282-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.